How it worksTechnologyClinical dataProductsCompanyGet updates

A Berlin medtech company built on one discovery

DiaMonTech AG develops non-invasive glucose measurement based on photothermal detection, invented by our co-founder Prof. Dr. Werner Mäntele.

Management

Thorsten LubinskiThorsten LubinskiCEO and co-founder. An entrepreneur who has built, grown and sold several companies.
Prof. Dr. Werner MänteleProf. Dr. Werner MänteleCSO and co-founder. Former professor of biophysics at Goethe University Frankfurt, inventor of the technology.
Sergius JanikSergius JanikCOO. Connects the scientific and the business side of the company.
Trillian GreggTrillian GreggHead of Product. A background in biophysics and years of translational product development.

Investors and funding

Funds go into European and US market entry and regulatory approvals.

8 M EUR

Financing round, September 2025, led by Companisto with business angels, venture capital, family offices and Samsung Next.

EIC 2026

Selected for the EIC Accelerator 2026 with the project NIGHT, Non-invasive Glucose Health Technology.

Priority access

Investors will have priority access to the first D-Pocket devices.

Certified processes

Quality management to ISO 13485:2016 for medical devices, information security to ISO 27001.

ISO 13485 certificate mark

Investor relations

Securities information sheet, annual general meeting documents and IPO questions: ir@diamontech.de or 030 275 870 52.

Be the first to hear when the D‑Pocket is ready

People with diabetes

Development news, study results and launch dates, a few times a year.

Investors

Securities information, general meeting and IPO questions.

ir@diamontech.de

Press

Images, interviews and background on the technology.

news@diamontech.de